HOME >> MEDICINE >> NEWS
Can we halt the deadly SARS?

AS CONCERN grows over the continuing spread of severe acute respiratory syndrome, or SARS, the key question is whether the disease can be contained. The answer will depend on how the virus spreads and evolves, which is still uncertain, and on whether healthcare systems, particularly in developing countries, can spot SARS and respond effectively.

So far, more than 1900 people in 22 countries have contracted SARS, of whom 63 have died. While China, Hong Kong and Singapore are hardest hit, some experts fear that poor public health monitoring in some countries may mean the number of cases is actually much higher.

The World Health Organization is bracing itself for outbreaks in countries currently claiming to be unaffected by SARS, including Cambodia, Indonesia and the Philippines. "We genuinely believe they have no cases at the moment. But we take the possibility of new outbreaks in this region very seriously," says Peter Cordingley, a spokesman for the WHO's Western Pacific headquarters in Manila.

The disease has so far been detected mainly in countries with good healthcare systems. But David Heymann, head of infectious diseases at the WHO in Geneva, says infected people may well have travelled to a country where an unexplained high fever and cough will not immediately draw attention. But the fact that SARS often infects healthcare workers could give it away, he says.

Even where healthcare facilities are good, it is extremely difficult to monitor an infection with such common symptoms and for which there is not yet a lab test. "With influenza, there is a well-defined test and a worldwide network set up to monitor it- and still there are nasty holes in that network," says Alan Hampson of the WHO Collaborating Centre for Reference and Research on Influenza in Melbourne, Australia.

India could already have undiagnosed cases, he says, as it only started checking airline passengers for SARS on 31 March. "Any country where the healthcare infrastructu
'"/>

Contact: Claire Bowles
claire.bowles@rbi.co.uk
44-207-331-2751
New Scientist
2-Apr-2003


Page: 1 2

Related medicine news :

1. Clot-busting drugs may help detect potentially deadly leg clots
2. Broken heart syndrome: Real, potentially deadly but recovery quick
3. University of Manchester uses crystals to help battle deadly diseases
4. Stanford study reveals that cells linked to asthma and eczema also help cure deadly illness in mice
5. New technology blocks gene to increase immune response against deadly brain tumor cells
6. Protein helps immune system mount instant strike against deadly flu viruses
7. Duke physicians predict risks of deadly infections after cord blood transplants
8. Small and deadly
9. Northwestern Memorial enrolling participants in two trials on new drug to fight deadly cancer
10. Stents combined with clot-busting drugs effective in limiting impact of deadly form of stroke
11. In lab studies, blocking expression of gene reduces invasion of deadly brain tumor cells

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Can halt the deadly SARS

(Date:4/14/2014)... been made in chemotherapy over the past decade, but ... continues to be a major challenge. , Nanotechnology ... the use of nanocarriers, or capsules, that can transport ... body. , The catch? These carriers are tiny, and ...
(Date:4/14/2014)... the 20th century, is currently losing a lot of ... at the University of South Carolina have just reported ... against so-called "superbugs." , Bacteria have been chipping away ... since their first wide-scale use as antibiotics in the ...
(Date:4/14/2014)... web information on colorectal cancer is too difficult for ... appropriate risks to and concerns of patients, a study ... a review of a dozen popular websites, most of ... were written beyond the recommended sixth-grade reading level, while ...
(Date:4/14/2014)... Inc., announced today a publication demonstrating that the company,s ... cells exposed to plasma samples of patients with a ... "TNT003, an inhibitor of the serine protease C1s, prevents ... was published on-line in the journal Blood ...
(Date:4/14/2014)... Child Development Institute have released their new study of ... success in kindergarten. According to FPG,s report, students enrolled ... of learning. , "Children are progressing at an ... than expected for normal developmental growth," said senior scientist ...
Breaking Medicine News(10 mins):Health News:Nano shake-up 2Health News:Penicillin redux: Rearming proven warriors for the 21st century 2Health News:Penicillin redux: Rearming proven warriors for the 21st century 3Health News:Website information on colon cancer too complex, fails to address key concerns 2Health News:Website information on colon cancer too complex, fails to address key concerns 3Health News:Ex vivo efficacy of C1s antibody as Complement inhibitor in cold agglutinin disease 2Health News:Study gives high marks to NC Pre-K program 2
(Date:1/15/2014)... , Jan. 15, 2014  Manufacturers, suppliers and distributors ... able to protect their most important business assets, ... ) Because of the highly-competitive ... remains one of the most litigious industry sectors ...
(Date:1/15/2014)... 2014 MultiCell Technologies, Inc. (OTC Bulletin Board: ... application concerning composition of matter, biological targets, mechanism of ... death.  This patent application describes a ... molecules (VSRNAs) which interfere with the basic homeostatic cellular ...
(Date:1/15/2014)... 2014  According to Millennium Research Group (MRG), the ... the United States and European ... expand moderately through 2022, with embolization particles representing ... interest in drug-eluting beads (DEBs) and radioembolization spheres ...
Breaking Medicine Technology:Intellectual Property Insurance for Medical-related Products and Services 2MultiCell Technologies Files Patent Application Covering New Class of RNA Therapeutics 2MultiCell Technologies Files Patent Application Covering New Class of RNA Therapeutics 3US and European Transcatheter Embolization and Occlusion Device Market to Surpass $1.6 Billion by 2022 2US and European Transcatheter Embolization and Occlusion Device Market to Surpass $1.6 Billion by 2022 3
Cached News: